PROSTATE CANCER CELL LINES, GENE SIGNATURES AND USES THEREOF
    11.
    发明申请
    PROSTATE CANCER CELL LINES, GENE SIGNATURES AND USES THEREOF 审中-公开
    前列腺癌细胞系,基因标志及其用途

    公开(公告)号:US20140109245A1

    公开(公告)日:2014-04-17

    申请号:US14003384

    申请日:2012-03-09

    摘要: The present disclosure, in part, is directed to a mammalian prostate cancer cell line comprising at least one or a set of primary mammalian epithelial cells which have been infected with a retroviral vector carrying an oncogene selected from the group consisting of c-Myc, Ha-Ras, NeuT, c-Src and combinations thereof and in which said gene is expressed. Applications of the pro-state cell lines, including immune competent animal models of prostate cancer, a method for the in vitro production of immortalized primary mammalian epithelial cells, a method of determining whether a human subject having prostate cancer is suffering from or at risk for developing metastasis, a method of preventing cancer or inhibiting metastasis of cancer susceptible to treatment in a subject at risk for developing cancer or metastasis of cancer, and method of identifying a candidate compound that selectively interferes with proliferation or viability of a cancer cell that has elevated levels of CCR5 and/or of at least one of its ligands.

    摘要翻译: 本公开部分地涉及包含至少一种或一组初级哺乳动物上皮细胞的哺乳动物前列腺癌细胞系,其已经携带携带癌基因的逆转录病毒载体感染,所述癌基因选自c-Myc,Ha -Ras,NeuT,c-Src及其组合,其中表达所述基因。 前体细胞系的应用,包括前列腺癌的免疫能力动物模型,用于体外产生永生化的原代哺乳动物上皮细胞的方法,确定具有前列腺癌的人类受试者是否患有或有风险的方法 发展转移,在发生癌症或癌症转移风险的受试者中预防癌症或抑制癌症转移的方法,以及鉴定选择性干扰具有升高的癌细胞的增殖或活力的候选化合物的方法 CCR5和/或其至少一种配体的水平。